vs
礼蓝动物保健（ELAN）与Rivian Automotive, Inc.（RIVN）财务数据对比。点击上方公司名可切换其他公司
Rivian Automotive, Inc.的季度营收约是礼蓝动物保健的1.1倍（$1.3B vs $1.1B），礼蓝动物保健净利率更高（-24.1% vs -63.1%，领先38.9%），礼蓝动物保健同比增速更快（12.2% vs -25.8%），礼蓝动物保健自由现金流更多（$46.0M vs $-1.1B），过去两年Rivian Automotive, Inc.的营收复合增速更高（3.3% vs -2.6%）
礼蓝动物保健是一家美国动物保健制药企业，专注于生产宠物及家畜用药品与疫苗。该公司原为礼来公司旗下子公司，2019年完成分拆独立，目前是全球第三大动物保健企业。
Rivian Automotive是2009年成立的美国电动汽车制造商及汽车科技企业，主打基于自研滑板平台打造的电动SUV、皮卡及EDV电动配送货车，旗下R1T皮卡于2021年末正式开启交付，还计划于2023年底前在美国和加拿大布局专属充电网络，其平台可适配新车型也可对外授权使用。
ELAN vs RIVN — 直观对比
营收规模更大
RIVN
是对方的1.1倍
$1.1B
营收增速更快
ELAN
高出38.0%
-25.8%
净利率更高
ELAN
高出38.9%
-63.1%
自由现金流更多
ELAN
多$1.2B
$-1.1B
两年增速更快
RIVN
近两年复合增速
-2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.3B |
| 净利润 | $-276.0M | $-811.0M |
| 毛利率 | 51.5% | 9.3% |
| 营业利润率 | -22.6% | -64.8% |
| 净利率 | -24.1% | -63.1% |
| 营收同比 | 12.2% | -25.8% |
| 净利润同比 | -3350.0% | -9.0% |
| 每股收益（稀释后） | $-0.55 | $-0.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ELANRIVN
| Q4 25 | $1.1B | $1.3B | ||
| Q3 25 | $1.1B | $1.6B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $1.2B | $1.2B | ||
| Q4 24 | $1.0B | $1.7B | ||
| Q3 24 | $1.0B | $874.0M | ||
| Q2 24 | $1.2B | $1.2B | ||
| Q1 24 | $1.2B | $1.2B |
净利润ELANRIVN
| Q4 25 | $-276.0M | $-811.0M | ||
| Q3 25 | $-34.0M | $-1.2B | ||
| Q2 25 | $11.0M | $-1.1B | ||
| Q1 25 | $67.0M | $-545.0M | ||
| Q4 24 | $-8.0M | $-744.0M | ||
| Q3 24 | $364.0M | $-1.1B | ||
| Q2 24 | $-50.0M | $-1.5B | ||
| Q1 24 | $32.0M | $-1.4B |
毛利率ELANRIVN
| Q4 25 | 51.5% | 9.3% | ||
| Q3 25 | 53.4% | 1.5% | ||
| Q2 25 | 57.5% | -15.8% | ||
| Q1 25 | 57.3% | 16.6% | ||
| Q4 24 | 50.9% | 9.8% | ||
| Q3 24 | 52.2% | -44.9% | ||
| Q2 24 | 58.2% | -38.9% | ||
| Q1 24 | 57.3% | -43.8% |
营业利润率ELANRIVN
| Q4 25 | -22.6% | -64.8% | ||
| Q3 25 | -4.4% | -63.1% | ||
| Q2 25 | 2.0% | -85.5% | ||
| Q1 25 | 5.0% | -52.8% | ||
| Q4 24 | -5.0% | -38.1% | ||
| Q3 24 | 54.3% | -133.8% | ||
| Q2 24 | -2.7% | -118.7% | ||
| Q1 24 | 1.0% | -123.3% |
净利率ELANRIVN
| Q4 25 | -24.1% | -63.1% | ||
| Q3 25 | -3.0% | -75.3% | ||
| Q2 25 | 0.9% | -85.7% | ||
| Q1 25 | 5.6% | -44.0% | ||
| Q4 24 | -0.8% | -42.9% | ||
| Q3 24 | 35.3% | -125.9% | ||
| Q2 24 | -4.2% | -125.8% | ||
| Q1 24 | 2.7% | -120.1% |
每股收益（稀释后）ELANRIVN
| Q4 25 | $-0.55 | $-0.66 | ||
| Q3 25 | $-0.07 | $-0.96 | ||
| Q2 25 | $0.02 | $-0.97 | ||
| Q1 25 | $0.13 | $-0.48 | ||
| Q4 24 | $-0.01 | $-0.67 | ||
| Q3 24 | $0.73 | $-1.08 | ||
| Q2 24 | $-0.10 | $-1.46 | ||
| Q1 24 | $0.06 | $-1.48 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $545.0M | $6.1B |
| 总债务越低越好 | $3.9B | — |
| 股东权益账面价值 | $6.5B | $4.6B |
| 总资产 | $13.4B | $14.9B |
| 负债/权益比越低杠杆越低 | 0.60× | — |
8季度趋势，按日历期对齐
现金及短期投资ELANRIVN
| Q4 25 | $545.0M | $6.1B | ||
| Q3 25 | $505.0M | $7.1B | ||
| Q2 25 | $539.0M | $7.5B | ||
| Q1 25 | $487.0M | $7.2B | ||
| Q4 24 | $468.0M | $7.7B | ||
| Q3 24 | $490.0M | $6.7B | ||
| Q2 24 | $416.0M | $7.9B | ||
| Q1 24 | $345.0M | $7.9B |
总债务ELANRIVN
| Q4 25 | $3.9B | — | ||
| Q3 25 | $4.0B | — | ||
| Q2 25 | $4.1B | — | ||
| Q1 25 | $4.4B | — | ||
| Q4 24 | $4.3B | — | ||
| Q3 24 | $4.4B | — | ||
| Q2 24 | $5.7B | $5.5B | ||
| Q1 24 | $5.8B | $4.4B |
股东权益ELANRIVN
| Q4 25 | $6.5B | $4.6B | ||
| Q3 25 | $6.7B | $5.1B | ||
| Q2 25 | $6.8B | $6.1B | ||
| Q1 25 | $6.4B | $6.2B | ||
| Q4 24 | $6.1B | $6.6B | ||
| Q3 24 | $6.5B | $5.9B | ||
| Q2 24 | $5.9B | $6.8B | ||
| Q1 24 | $6.1B | $8.1B |
总资产ELANRIVN
| Q4 25 | $13.4B | $14.9B | ||
| Q3 25 | $13.6B | $15.2B | ||
| Q2 25 | $13.7B | $15.6B | ||
| Q1 25 | $12.9B | $15.5B | ||
| Q4 24 | $12.6B | $15.4B | ||
| Q3 24 | $13.3B | $14.3B | ||
| Q2 24 | $13.8B | $15.4B | ||
| Q1 24 | $14.0B | $15.7B |
负债/权益比ELANRIVN
| Q4 25 | 0.60× | — | ||
| Q3 25 | 0.59× | — | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 0.69× | — | ||
| Q4 24 | 0.70× | — | ||
| Q3 24 | 0.67× | — | ||
| Q2 24 | 0.96× | 0.81× | ||
| Q1 24 | 0.95× | 0.55× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $108.0M | $-681.0M |
| 自由现金流经营现金流 - 资本支出 | $46.0M | $-1.1B |
| 自由现金流率自由现金流/营收 | 4.0% | -89.0% |
| 资本支出强度资本支出/营收 | 5.4% | 36.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $284.0M | $-2.5B |
8季度趋势，按日历期对齐
经营现金流ELANRIVN
| Q4 25 | $108.0M | $-681.0M | ||
| Q3 25 | $219.0M | $26.0M | ||
| Q2 25 | $237.0M | $64.0M | ||
| Q1 25 | $-4.0M | $-188.0M | ||
| Q4 24 | $177.0M | $1.2B | ||
| Q3 24 | $162.0M | $-876.0M | ||
| Q2 24 | $200.0M | $-754.0M | ||
| Q1 24 | $2.0M | $-1.3B |
自由现金流ELANRIVN
| Q4 25 | $46.0M | $-1.1B | ||
| Q3 25 | $127.0M | $-421.0M | ||
| Q2 25 | $180.0M | $-398.0M | ||
| Q1 25 | $-69.0M | $-526.0M | ||
| Q4 24 | $130.0M | $856.0M | ||
| Q3 24 | $120.0M | $-1.2B | ||
| Q2 24 | $166.0M | $-1.0B | ||
| Q1 24 | $-22.0M | $-1.5B |
自由现金流率ELANRIVN
| Q4 25 | 4.0% | -89.0% | ||
| Q3 25 | 11.2% | -27.0% | ||
| Q2 25 | 14.5% | -30.5% | ||
| Q1 25 | -5.8% | -42.4% | ||
| Q4 24 | 12.7% | 49.4% | ||
| Q3 24 | 11.7% | -131.9% | ||
| Q2 24 | 14.0% | -89.6% | ||
| Q1 24 | -1.8% | -126.5% |
资本支出强度ELANRIVN
| Q4 25 | 5.4% | 36.0% | ||
| Q3 25 | 8.1% | 28.7% | ||
| Q2 25 | 4.6% | 35.5% | ||
| Q1 25 | 5.4% | 27.3% | ||
| Q4 24 | 4.6% | 18.9% | ||
| Q3 24 | 4.1% | 31.7% | ||
| Q2 24 | 2.9% | 24.4% | ||
| Q1 24 | 2.0% | 21.1% |
现金转化率ELANRIVN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 21.55× | — | ||
| Q1 25 | -0.06× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.45× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.06× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ELAN
| Pet Health | $489.0M | 43% |
| Cattle | $296.0M | 26% |
| Poultry | $237.0M | 21% |
| Swine | $107.0M | 9% |
| Contract Manufacturing | $15.0M | 1% |
RIVN
| Automotive Segment | $839.0M | 65% |
| Software And Services Segment | $447.0M | 35% |
| Regulatory Credits | $30.0M | 2% |
